|
Sign In to gain access to subscriptions and/or personal tools.
|
Lipid-lowering therapy is associated with resolution of exudates in diabetic maculopathy
Hiten G Sheth
Department of Ophthalmology, Chelsea & Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK, drhitensheth{at}yahoo.co.uk
Sher Aslam
Department of Ophthalmology, Chelsea & Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK
Michael D Feher
Beta Cell Diabetes Centre and Department of Medicine, Chelsea & Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK
Nigel Davies
Department of Ophthalmology, Chelsea & Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK
References
- Gupta A., Gupta V., Thapar S., Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular oedema. Am J Ophthalmol 2004;137:675-82.[Web of Science][Medline]
[Order article via Infotrieve]
- Zander E., Herfurt S., Bohl B. et al. Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol 2000;84:871-6.[Abstract/Free Full Text]
- Cusick M., Chew EY, Chan CC, Kruth HS, Murphy RP, Ferris FL 3rd. Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology 2003;110:2126-33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Klein R., Klein BE, Moss SE, Davis MD, DeMets DL The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107:244-49.[Abstract/Free Full Text]
- Chew EY, Klein ML, Ferris FL 3rd et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 1996;114:1079-84.[Abstract/Free Full Text]
- Mohan R., Mohan V., Susheela L., Ramachandran A., Viswanathan M. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy. Acta Diabetol Lat 1984;21:85-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Chowdhury TA, Hopkins D., Dodson PM, Vafidis GC The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? Eye 2002;16:689-93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus: randomised controlled trial. Lancet 2005;366:1849-61.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Duncan LJ, Cullen JF, Ireland JT et al. A three-year trial of atromid therapy in exudative diabetic retinopathy. Diabetes 1968;17:458-67.[Web of Science][Medline]
[Order article via Infotrieve]
- Harrold BP, Marmion VJ, Gough KR A double-blind controlled trial of the use of clofibrates in the treatment of Diabetic Retinopathy. Diabetes 1969;18:285-91.[Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 6, No. 4,
181-183 (2006)
DOI: 10.1177/14746514060060040701

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|